Zobrazeno 1 - 10
of 28
pro vyhledávání: '"James J. Gormley"'
Autor:
James J. Gormley, Vijaya Juturu
Publikováno v:
Current Nutrition & Food Science. 1:1-11
Metabolic syndrome risk factors (MSRF) can lead to cardiovascula r disease (CVD) and its prevalence is increasing at an alarming rate in the United States and worldwide. Pathways leading directly from visceral adiposity to the genesis of free fatty a
Autor:
Anand S. Dutta, Amanda Rees, Alec Jamieson, Duncan Haworth, Rod S. Kittlety, Lorraine A. Hassall, Paul Gellert, James J. Gormley, Christopher F. Reilly, Peter J. Alcock, Christopher F. Hayward, Linda J. Wood, Mandy L. Crowther, Julie M. Moores
Publikováno v:
Journal of Peptide Science. 6:321-341
Potent monomeric and dimeric cyclic peptide very late antigen-4 (VLA-4) inhibitors have been designed based on a tetrapeptide (Ile-Leu-Asp-Val) sequence present in a 25-amino acid peptide (CS-1) reported in the literature. The peptides, synthesized b
Autor:
Paul Gellert, Peter J. Alcock, Duncan Haworth, Anand S. Dutta, Tracy Halterman, Roger Ferguson, Linda J. Wood, Julie M. Moores, Lorraine A. Hassall, Christopher F. Hayward, James J. Gormley, Christopher F. Reilly, Matthew M Coath, Jackie Moors, Amanda Rees, Rod S. Kittlety, Alec Jamieson
Publikováno v:
Journal of Peptide Science. 6:398-412
Additional structure–activity relationship studies on potent cyclic peptide inhibitors of very late antigen-4 (VLA-4) are reported. The new N- to C-terminal cyclic hexa-, hepta- and octapeptide inhibitors like cyclo(MeIle/MePhe-Leu-Asp-Val-X) (X=2
Autor:
Peter J. Alcock, Amanda Rees, Anand S. Dutta, Alec Jamieson, Christopher F. Reilly, Duncan Haworth, Huw B Jones, Linda J. Wood, James J. Gormley
Publikováno v:
British Journal of Pharmacology. 126:1751-1760
1. Small, N- to C-terminal cyclized peptides containing the leucyl-aspartyl-valine (LDV) motif from fibronectin connecting segment-1 (CS-1) have been investigated for their effects on the adhesion of human T-lymphoblastic leukaemia cells (MOLT-4) to
Autor:
James J. Gormley, Vijaya Juturu
Coronary heart disease (CHD) accounts for the majority of cardiovascular disease (CVD) deaths in men and women. Abnormal function of the heart and blood vessels increases the risk for heart attack, heart failure, sudden death, stroke, and cardiac rhy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d717f4a434697665c8739b637152a32
https://doi.org/10.1016/b978-0-12-396485-4.00003-7
https://doi.org/10.1016/b978-0-12-396485-4.00003-7
Autor:
Vijaya Juturu, James J. Gormley
Publikováno v:
Modern Dietary Fat Intakes in Disease Promotion ISBN: 9781603275705
• To formulators, hydrogenated vegetable oils provide distinctive flavor, crispness, creaminess, plasticity, and oxidation stability. Refinement of the industrial technology of partial hydrogenation and appropriate food labeling may lead to a consi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b14938e903af9d2d540ace372f84dc86
https://doi.org/10.1007/978-1-60327-571-2_5
https://doi.org/10.1007/978-1-60327-571-2_5
Autor:
Vijaya Juturu, James J. Gormley
Publikováno v:
Wild-Type Food in Health Promotion and Disease Prevention ISBN: 9781588296689
Recent data strongly suggest that atherosclerosis progression may be slowed by increased intakes of essential fatty acids (EFAs) from fish even in diabetes. The current evidence also indicates the potential benefits of EFAs on atrial fibrillation, pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcc5af7eab060eb9e30836463e4d69b0
https://doi.org/10.1007/978-1-59745-330-1_18
https://doi.org/10.1007/978-1-59745-330-1_18
Publikováno v:
Journal of Medicinal Chemistry. 33:2560-2568
Cyclic peptides containing a D-phenylalanine and a D-tryptophan residue have been synthesized and tested as inhibitors of human renin. Most of these are tripeptide derivatives of the type CO(CH2)3CO-D-Phe-Lys-D-Trp- or COCH2NHCH2CO-D-Phe-Lys-D-Trp- i
Autor:
Russell C. Mauger, Darleen Lloyd, James J. Gormley, Stephen J. Hubbs, Anne M. Strimpler, Philip D. Edwards, Mark Sylvester, Clay W Scott, Stephen T. Furlong, Anand S. Dutta, Matthew M Coath
Publikováno v:
Immunopharmacology. 48(2)
C3 convertase is a key enzyme in the complement cascade and is an attractive therapeutic target for drug design. Recent studies have demonstrated that this enzyme is inhibited by compstatin (Morikis, D. , Assa-Munt, N., Sahu, A., Lambris, J.D., 1998.
Autor:
Andrew Garner, Roger Camble, Joseph R. Best, Peter B. Scholes, James J. Gormley, Ronald Cotton, Christopher F. Hayward, Peter F. McLachlan, Anand S. Dutta, Bridget Fleming
Publikováno v:
Biochemical Society Transactions. 18:1294-1296